1998
Do molecular markers predict survival in non-small-cell lung cancer? Am J Respir Crit Care Med. 1998;157(4 Pt 1):1093-7.
Pooled analysis of p53 mutations in hematological malignancies. Hum Mutat. 1998;12(1):4-18.
Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen. J Biol Chem. 1998;273(47):31480-5.
Epithelioid haemangioendothelioma of the thyroid gland: a case report and review of literature. Histopathology. 1998;32(5):473-6.
In vitro studies of the interactions between platelets and amniotic membranes: a potential treatment for preterm premature rupture of the membranes. Am J Obstet Gynecol. 1998;178(2):287-93.
Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A. 1998;95(4):1735-40.
Clinical and molecular prognostic factors in sphincter-preserving surgery for rectal cancer. Semin Radiat Oncol. 1998;8(1):54-69.
Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol Cell Biol. 1998;18(5):3069-80.